Get the app
US › Healthcare

Briacell Therapeutics Corp (BCTX)

US · Healthcare · Biotechnology

$3.95+20.80%
Last close · 2026-11-06

Latest quarter · ended 2026-07-31

Revenue
$0
Revenue YoY
-100.0%
Net profit
$-12.3M
EPS
$-1.24

Key statistics

Market cap
$26.5M
Forward P/E
0.0
P/B
1.78
Book value
$1.88
EPS (TTM)
$-6.37
52-week high
$13.09
52-week low
$2.60
50-day MA
$3.77
200-day MA
$3.81
Beta
1.51

Analyst view

with an average price target of $150.00.

Shareholding

Insiders
0.14%
Institutions
6.39%

Largest institutional holders

FundStake
Cable Car Capital LLC2.49%
Sabby Management LLC0.93%
Iridian Asset Management LLC0.75%
UBS Group AG0.50%
HRT FINANCIAL LLC0.40%
Jane Street Group LLC0.30%
LuminArx Capital Management LP0.17%
NATIONAL BANK OF CANADA /FI/0.02%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Briacell Therapeutics Corp — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-11-07.